Kintor Pharmaceutical Ltd
Company Profile
Business description
Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China focused on the proprietary R&D of drugs for cancers and other AR-related diseases. The company's drug candidate, Pruxelutamide, is a drug undergoing phase III clinical trials in China and phase III clinical trials in the United States for mCRPC as well as clinical trials for breast cancer. Its pipeline of seven drug candidates includes Pruxelutamide (GT0918), Pyrilutamide (KX-826), ALK-1 (GT90001), Detorsertib (GT0486), Hedgehog/SMO Inhibitor (GT1708F), PD-L1/TGF-B (GT90008), and AR-PROTAC Compound (GT20029). The company operates in a single segment focusing on the research and development of medical products.
Contact
No. 20 Songbei Road
Suzhou Industrial Park
Jiangsu
Suzhou 215123
CHNT: +86 51262639909
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
225
Stocks News & Analysis
stocks
One of the hottest shares on the ASX reports strong growth
stocks
Diverging value in Australia's real estate sector
stocks
Going into earnings, is Amazon stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,094.30 | 111.20 | -1.36% |
| CAC 40 | 7,427.02 | 86.71 | -1.15% |
| DAX 40 | 18,298.72 | 88.74 | -0.48% |
| Dow JONES (US) | 39,935.07 | 81.20 | 0.20% |
| FTSE 100 | 8,186.35 | 32.66 | 0.40% |
| HKSE | 17,004.97 | 306.08 | -1.77% |
| NASDAQ | 17,181.72 | 160.69 | -0.93% |
| Nikkei 225 | 37,869.51 | 1,285.34 | -3.28% |
| NZX 50 Index | 12,371.52 | 24.75 | -0.20% |
| S&P 500 | 5,399.22 | 27.91 | -0.51% |
| S&P/ASX 200 | 7,861.20 | 102.50 | -1.29% |
| SSE Composite Index | 2,886.74 | 15.21 | -0.52% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.13% |
| Argosy Minerals Ltd AGY | 0.03 | 0.02 | -30.61% |
| Red 5 Ltd RED | 0.40 | 0.02 | -4.82% |
| Zip Co Ltd ZIP | 1.81 | 0.02 | -0.82% |
| Peninsula Energy Ltd PEN | 0.10 | 0.01 | -4.76% |
| Core Lithium Ltd CXO | 0.09 | 0.00 | -3.19% |
| Medibank Private Ltd MPL | 3.83 | 0.00 | 0.00% |
| Arafura Rare Earths Ltd ARU | 0.17 | 0.03 | -13.16% |
| Syrah Resources Ltd SYR | 0.27 | 0.04 | -11.67% |
| BrainChip Holdings Ltd BRN | 0.21 | 0.01 | 2.50% |